| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 1,085 | 1,152 | 1,150 | 1,024 | 1,106 | 1,176 | 1,257 | 1,630 | 1,164 | 1,229 | 1,258 | 1,175 | 1,108 | 1,081 | 1,156 | 1,164 | 1,528 | 1,170 | 1,277 | 1,178 | 1,133 | 614 | 1,029 | 1,205 | 1,278 | 1,733 | 1,475 | 1,487 | 1,391 | 1,519 | 1,682 | 1,586 | 1,669 | 1,667 | 1,788 | 1,699 | 1,803 | 1,873 | 2,006 | 1,975 | 2,032 |
| Expenses | 1,022 | 986 | 1,087 | 1,066 | 1,091 | 1,059 | 1,097 | 1,023 | 1,045 | 1,071 | 1,138 | 1,069 | 1,907 | 1,034 | 1,172 | 1,193 | 1,069 | 996 | 1,028 | 1,012 | 987 | 709 | 875 | 987 | 1,055 | 1,135 | 1,178 | 1,180 | 1,157 | 1,237 | 1,304 | 1,283 | 1,372 | 1,386 | 1,440 | 1,396 | 1,405 | 1,516 | 1,613 | 1,553 | 1,625 |
| EBITDA | 62 | 166 | 62 | -42 | 15 | 118 | 160 | 607 | 118 | 158 | 120 | 106 | -799 | 47 | -16 | -29 | 459 | 174 | 250 | 166 | 146 | -96 | 155 | 218 | 223 | 598 | 297 | 307 | 234 | 282 | 378 | 302 | 297 | 282 | 349 | 303 | 398 | 356 | 393 | 422 | 406 |
| Operating Profit % | 3 % | 4 % | -2 % | -5 % | -2 % | 6 % | 8 % | 10 % | 7 % | 7 % | 5 % | 5 % | -76 % | 1 % | -3 % | -8 % | 10 % | 13 % | 15 % | 13 % | 11 % | -17 % | 12 % | 16 % | 16 % | 20 % | 19 % | 20 % | 16 % | 17 % | 19 % | 18 % | 16 % | 16 % | 19 % | 17 % | 21 % | 18 % | 19 % | 19 % | 19 % |
| Depreciation | 61 | 53 | 0 | 0 | 72 | 48 | 52 | 60 | 63 | 59 | 61 | 59 | 60 | 57 | 56 | 60 | 60 | 71 | 71 | 70 | 80 | 72 | 74 | 73 | 72 | 73 | 75 | 76 | 77 | 74 | 77 | 83 | 82 | 79 | 84 | 87 | 92 | 91 | 95 | 97 | 102 |
| Interest | 37 | 34 | 30 | 32 | 38 | 42 | 46 | 75 | 67 | 64 | 66 | 63 | 64 | 76 | 85 | 111 | 65 | 51 | 49 | 48 | 57 | 41 | 42 | 42 | 41 | 38 | 40 | 38 | 30 | 31 | 33 | 33 | 32 | 32 | 32 | 33 | 35 | 35 | 36 | 45 | 68 |
| Profit Before Tax | -22 | 88 | 44 | -58 | -96 | 28 | 62 | 472 | -11 | 35 | -7 | -17 | -924 | -87 | -157 | -201 | 334 | 52 | 130 | 48 | 9 | -208 | 38 | 103 | 110 | 486 | 182 | 193 | 126 | 176 | 268 | 186 | 183 | 171 | 233 | 183 | 271 | 230 | 261 | 279 | 237 |
| Tax | -10 | -9 | -17 | -29 | -8 | 3 | 24 | 19 | 26 | 12 | 17 | 3 | -9 | -34 | -15 | -20 | 183 | -26 | 6 | 118 | 50 | -20 | 23 | 49 | 48 | 56 | 51 | 51 | 39 | 42 | 50 | 44 | 45 | 47 | 49 | 49 | 68 | 56 | 68 | 25 | 49 |
| Net Profit | -12 | 97 | 61 | -29 | -88 | 25 | 38 | 453 | -38 | 23 | -24 | -19 | -914 | -53 | -142 | -180 | 151 | 78 | 124 | -69 | -41 | -188 | 16 | 54 | 62 | 431 | 131 | 142 | 87 | 134 | 218 | 142 | 138 | 124 | 184 | 134 | 203 | 174 | 193 | 254 | 188 |
| EPS in ₹ | -0.38 | 2.01 | 1.19 | -0.65 | -1.91 | 0.35 | 0.68 | 9.49 | -0.79 | 0.10 | -0.88 | -0.71 | -17.97 | -1.36 | -3.21 | -3.06 | 1.80 | 0.90 | 1.47 | -1.01 | -0.59 | -2.37 | -0.05 | 0.40 | 0.57 | 3.49 | 1.42 | 1.55 | 0.90 | 1.62 | 2.71 | 1.72 | 1.76 | 1.48 | 2.30 | 1.78 | 2.37 | 2.20 | 2.34 | 3.28 | 2.44 |
Fortis Healthcare
754.00
-6.00
(-0.79%)
Market Cap
56,923.84 Cr
EPS
7.93
PE Ratio
67.72
Dividend Yield
0.13 %
Industry
Healthcare Services52 Week High
781.00
52 Week Low
453.00
PB Ratio
6.43
Debt to Equity
0.14
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from12 analysts
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,232.80 | #1 1,19,845.67 | 103.24 | 5,584.10 | 18.77 | #1 1,058 | 26.84 | 65.57 | |
6,994.50 | 1,00,570.18 | 69.56 | #1 19,165.50 | 14.74 | 917 | 60.41 | 54.94 | |
754.00 | #3 56,923.84 | #6 67.72 | #2 6,931.20 | #10 8.99 | #4 645 | #9 -7.43 | 61.43 | |
1,913.00 | 39,094.22 | 46.72 | 5,093.40 | 10.96 | 790 | 3.41 | 72.28 | |
1,186.00 | 31,854.46 | 61.36 | 2,759.20 | #1 25.09 | 326 | -20.35 | 44.55 | |
569.70 | 28,457.26 | 78.83 | 3,723.70 | 22.85 | 205 | #1 3,986.36 | 56.74 | |
679.95 | 27,207.45 | 70.28 | 2,511.20 | 12.94 | 336 | 48.39 | 57.38 | |
5,937.00 | 15,069.17 | #1 31.30 | 599.90 | 11.69 | 58 | 4.79 | 50.22 | |
1,421.60 | 14,436.59 | 60.78 | 1,334.00 | 10.76 | 218 | 10.57 | 54.41 | |
1,524.30 | 9,994.23 | 52.12 | 1,095.50 | 21.32 | 177 | -0.88 | 59.97 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
8.99 %
Net Income Growth
1.93 %
Cash Flow Change
33.79 %
ROE
-3.46 %
ROCE
14.14 %
EBITDA Margin (Avg.)
3.01 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 7,616 | 7,232 | 9,717 | 8,622 | 11,951 | 11,348 | 11,155 | 11,885 | 12,434 | 13,289 |
| Fixed Assets | 4,218 | 3,776 | 5,419 | 4,992 | 8,477 | 8,802 | 8,799 | 9,416 | 9,426 | 9,874 |
| Current Assets | 1,636 | 1,434 | 1,775 | 1,282 | 1,667 | 941 | 1,037 | 1,133 | 1,406 | 1,421 |
| Capital Work in Progress | 228 | 201 | 268 | 226 | 450 | 204 | 165 | 194 | 228 | 542 |
| Investments | 616 | 1,449 | 1,878 | 1,732 | 270 | 175 | 186 | 104 | 210 | 230 |
| Other Assets | 2,554 | 1,807 | 2,152 | 1,672 | 2,755 | 2,167 | 2,005 | 2,172 | 2,569 | 2,643 |
| Total Liabilities | 7,616 | 7,232 | 9,717 | 8,622 | 11,951 | 11,348 | 11,155 | 11,885 | 12,434 | 13,289 |
| Current Liabilities | 1,602 | 1,476 | 1,927 | 2,134 | 3,591 | 2,579 | 1,233 | 1,269 | 1,426 | 3,170 |
| Non Current Liabilities | 1,813 | 1,616 | 1,480 | 1,171 | 1,248 | 1,563 | 3,204 | 3,607 | 2,907 | 1,563 |
| Total Equity | 4,201 | 4,140 | 6,311 | 5,317 | 7,113 | 7,206 | 6,718 | 7,008 | 8,100 | 8,556 |
| Reserve & Surplus | 3,585 | 3,534 | 4,626 | 3,543 | 5,846 | 5,906 | 5,365 | 5,423 | 6,487 | 6,908 |
| Share Capital | 463 | 463 | 518 | 519 | 755 | 755 | 755 | 755 | 755 | 755 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -66 | -38 | 225 | -513 | 799 | -627 | 212 | -153 | -22 | 125 |
| Investing Activities | 213 | 122 | -1,001 | -333 | -3,279 | 64 | -131 | -501 | -373 | -889 |
| Operating Activities | 24 | 195 | 967 | 493 | -179 | 172 | 486 | 865 | 822 | 1,100 |
| Financing Activities | -304 | -354 | 259 | -672 | 4,257 | -862 | -143 | -517 | -471 | -87 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
| Promoter | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % | 31.17 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 26.32 % | 0.00 % | 23.24 % | 23.31 % | 25.26 % | 26.77 % | 27.40 % |
| DIIs | 13.44 % | 15.20 % | 15.66 % | 15.50 % | 16.72 % | 17.44 % | 19.94 % | 20.38 % | 20.70 % | 22.16 % | 26.55 % | 29.35 % | 31.15 % | 32.31 % | 30.73 % | 30.05 % | 29.46 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 13.96 % | 15.16 % | 15.98 % | 14.89 % | 13.96 % | 13.58 % | 12.92 % | 12.39 % | 12.05 % | 11.80 % | 11.13 % | 11.04 % | 10.82 % | 10.47 % | 10.36 % | 10.21 % | 10.22 % |
| Others | 41.43 % | 38.47 % | 37.20 % | 38.44 % | 38.15 % | 37.82 % | 35.98 % | 36.06 % | 36.08 % | 34.86 % | 4.83 % | 28.44 % | 3.63 % | 2.75 % | 2.48 % | 1.81 % | 1.75 % |
| No of Share Holders | 0 | 1,09,889 | 1,44,634 | 1,66,743 | 1,54,572 | 1,56,881 | 1,60,762 | 1,58,455 | 1,37,894 | 1,35,047 | 1,31,516 | 1,35,664 | 1,57,165 | 1,54,260 | 2,04,184 | 2,21,750 | 2,18,329 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.14 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 May 2025 |  Quarterly Result Announcement | NA | 20 May 2025 | 682.75 | 685.85 |
| 07 Feb 2025 | Quarterly Result Announcement | NA | 07 Feb 2025 | 581.00 | 651.05 |
| 08 Nov 2024 | Quarterly Result Announcement | NA | 08 Nov 2024 | 601.65 | 623.10 |
| 02 Aug 2024 |  Annual General Meeting | NA | 02 Aug 2024 | 471.55 | 505.05 |
| 24 Jul 2024 |  Dividend | ₹ 1.00 /share | 24 Jul 2024 | 469.50 | 487.45 |
| 20 Jul 2023 | Dividend | ₹ 1.00 /share | 20 Jul 2023 | 289.05 | 328.75 |
Announcements
Compliances-Reg.24(A)-Annual Secretarial Compliance
May 28, 2025
May 28, 2025Updates On Acquisition - Shrimann HospitalMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 28, 2025
May 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 21, 2025
May 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
May 21, 2025Statement Of Utilization And Deviation Or Variation In The Use Of Proceeds Of Issue Of Listed Non-Convertible Debentures (Ncds)May 20, 2025
May 20, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations &
Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).May 20, 2025
May 20, 2025Compliance With Respect To The Regulation 56(1)(D) Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 And Other Relevant Provisions.May 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 20, 2025
May 20, 2025Compliances-Reg. 54 - Asset Cover details May 20, 2025
May 20, 2025Revision In Policies.May 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
May 20, 2025Appointment Of Secretarial Auditors And Cost Auditors.May 20, 2025
May 20, 2025Corporate Action-Board approves DividendMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 20, 2025
May 20, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
May 20, 2025Outcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015May 20, 2025
May 20, 2025Board Meeting Outcome for Outcome Of The Board Meeting Under Regulation 30 33 51(2) And Regulation 52 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements)
Regulations 2015May 20, 2025
May 20, 2025Reschedule Of Investors/ Ananlysts CallMay 16, 2025
May 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 16, 2025
May 16, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 09, 2025
May 09, 2025Board Meeting Intimation for Notice Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 08, 2025
May 08, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015May 05, 2025
May 05, 2025Disclosure Under Chapter XIV - Centralized Database For Corporate Bonds/ Debentures Of SEBI Master Circular Dated May 22 2024.Apr 30, 2025
Apr 30, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 25, 2025
Apr 25, 2025Compliances-Half Yearly Report (SEBI Circular No. CIR/IMD/DF-1/67/2017) Apr 10, 2025
Apr 10, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Apr 03, 2025
Apr 03, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 03, 2025
Apr 03, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderApr 02, 2025
Apr 02, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) - Regarding Fortis Trademarks And Allied Trademarks.Apr 02, 2025
Apr 02, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 21, 2025
Mar 21, 2025Update On Acquisition Announcement Dated February 14 2025Mar 21, 2025
Mar 21, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 20, 2025
Mar 20, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 20, 2025
Mar 20, 2025Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015.Mar 20, 2025
Mar 20, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 19, 2025
Feb 19, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Feb 14, 2025Acquisition Of Shrimann Superspecialty Hospital.Feb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-AcquisitionFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2025
Feb 08, 2025Statement Of Deviation And Variation.Feb 07, 2025
Feb 07, 2025Technical Indicators
RSI(14)
Neutral 61.43
ATR(14)
Less Volatile 21.43
STOCH(9,6)
Overbought 82.30
STOCH RSI(14)
Neutral 45.90
MACD(12,26)
Bullish 1.93
ADX(14)
Strong Trend 33.54
UO(9)
Bearish 59.93
ROC(12)
Uptrend And Accelerating 6.11
WillR(14)
Neutral -32.81
Mutual Fund Holdings
| Funding House | No of Shares | Current Holding % | 1M Change % | 3M Change % | Month | |
|---|---|---|---|---|---|---|
 Mirae Asset Large & Midcap Fund Direct-Growth | 923041 | 0.17% | -0.33% | -0.65% | May 2025 | |
 HDFC Small Cap Fund Direct- Growth | 10073132 | 2.09% | -0.43% | -0.79% | May 2025 | |
 Edelweiss Mid Cap Direct Plan-Growth | 2865466 | 2.02% | 0.27% | 0.15% | May 2025 | |
| Edelweiss Small Cap Fund Direct - Growth | 1032889 | 1.59% | 0.30% | 0.22% | May 2025 | |
 Kotak Equity Opportunities Fund Direct-Growth | 2700000 | 0.71% | 0.04% | 0.07% | May 2025 | |
 Baroda BNP Paribas Midcap Fund Direct-Growth | 500000 | 1.65% | 0.64% | 1.65% | May 2025 | |
 Bandhan Midcap Fund Direct-Growth | 189070 | 0.79% | 0.79% | 0.79% | May 2025 | |
 Sundaram Multi Asset Allocation Fund Direct - Growth | 181000 | 0.49% | 0.49% | 0.49% | May 2025 | |
 Axis Large & Mid Cap Fund Direct-Growth | 2757361 | 1.36% | 0.07% | 0.00% | May 2025 | |
| Bandhan Large Cap Fund Direct-Growth | 126392 | 0.48% | 0.48% | 0.48% | May 2025 | |
| Kotak India EQ Contra Fund Direct-Growth | 1115600 | 1.84% | 0.16% | 0.29% | May 2025 | |
 Shriram Multi Sector Rotation Fund Direct-Growth | 163200 | 5.92% | 4.15% | 2.97% | May 2025 | |
 LIC MF Aggressive Hybrid Fund Direct-Growth | 102235 | 1.36% | 1.36% | 1.36% | May 2025 | |
| Bandhan Innovation Fund Direct-Growth | 101199 | 0.47% | 0.47% | 0.47% | May 2025 | |
 WhiteOak Capital Mid Cap Fund Direct - Growth | 804152 | 1.78% | 0.10% | 0.60% | May 2025 | |
 Bajaj Finserv Consumption Fund Direct-Growth | 85000 | 1.05% | 1.05% | 1.05% | May 2025 | |
| Bandhan Aggressive Hybrid Fund Direct-Growth | 83880 | 0.66% | 0.66% | 0.66% | May 2025 | |
 Aditya Birla Sun Life Equity Advantage Fund Direct -Growth | 1180073 | 1.45% | -0.12% | -0.17% | May 2025 | |
| Bajaj Finserv Healthcare Fund Direct-Growth | 78000 | 1.72% | 1.72% | 1.72% | May 2025 | |
| Mirae Asset Healthcare Fund Direct - Growth | 933101 | 2.45% | 0.26% | 0.15% | May 2025 | |
| WhiteOak Capital Pharma and Healthcare Fund Direct - Growth | 240535 | 5.12% | 1.58% | 1.31% | May 2025 | |
 JM Midcap Fund Direct - Growth | 300000 | 1.52% | -0.42% | -0.55% | May 2025 | |
| Edelweiss Consumption Fund Direct-Growth | 53945 | 1.05% | 1.05% | 1.05% | May 2025 | |
| Kotak Nifty Midcap 150 Momentum 50 Index Fund Direct-Growth | 97666 | 3.19% | -0.09% | -0.27% | May 2025 | |
 Nippon India Active Momentum Fund Direct-Growth | 41018 | 1.61% | 1.61% | 1.61% | May 2025 |
About Fortis Healthcare
Fortis Healthcare Limited is one of India's largest healthcare providers, operating 27 hospitals with 4,500 operational beds and over 426 diagnostics centres as of March 31, 2023. The company offers a wide range of integrated healthcare services including cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology, and mother and child care. Fortis uses advanced technology to deliver quality healthcare in modern facilities. Its subsidiary, SRL Limited, is a leading diagnostics chain in India. Fortis Healthcare has a presence in India, Dubai, Mauritius, and Sri Lanka. The company has expanded through acquisitions and new facility launches over the years, focusing on its core Indian market in recent times. It provides inpatient and outpatient services, sells medical and non-medical items, and offers management services to hospitals. Fortis Healthcare's specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant.
Listing Date
09 May, 2007(18 Years,
6 days)
Chairperson NameLeo Puri
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
